Department of Hepatology, The First Hospital of Jilin University.
Department of Thoracic Surgery, The Second Hospital of Jilin University, Changchun, Jilin China.
Eur J Gastroenterol Hepatol. 2019 Jul;31(7):743-748. doi: 10.1097/MEG.0000000000001419.
Development of hepatocellular carcinoma (HCC) is usually preceded by chronic liver injury and ongoing liver diseases. Liver cirrhosis reflects the outcome of long-term liver injury and is associated with an increased risk of developing HCC. However, HCC also arises in individuals without cirrhosis and bears several characteristics distinct from HCC in the cirrhotic liver. The molecular characteristics, prognosis, and surveillance of noncirrhotic HCC have not been adequately studied. In this review, we update readers and researchers in the field with the latest understanding of the epidemiology, etiology, clinical features, diagnosis, treatment strategies, prognosis, and surveillance of noncirrhotic HCC.
肝细胞癌(HCC)的发生通常先于慢性肝损伤和持续存在的肝脏疾病。肝硬化反映了长期肝损伤的结果,并与发生 HCC 的风险增加相关。然而,HCC 也发生在没有肝硬化的个体中,并且具有与肝硬化肝脏中的 HCC 不同的几个特征。非肝硬化 HCC 的分子特征、预后和监测尚未得到充分研究。在这篇综述中,我们为该领域的读者和研究人员提供了关于非肝硬化 HCC 的流行病学、病因学、临床特征、诊断、治疗策略、预后和监测的最新认识。